Pediatrics, Child and Adolescent Health (Series Editor: Joav Merrick - National Institute of Child Health and Human Development, Ministry of Social Affairs, Jerusalem) Ser.: Clinical Aspects of Psychopharmacology in Childhood and Adolescence by Joseph L. Calles (2017, Hardcover)

Great Book Prices Store (336060)
96.5% positive Feedback
Price:
US $196.37
Approximately£144.91
+ $19.99 postage
Estimated delivery Mon, 16 Jun - Thu, 19 Jun
Returns:
14 days return. Buyer pays for return postage. If you use an eBay delivery label, it will be deducted from your refund amount.
Condition:
New
Clinical Aspects of Psychopharmacology in Childhood and Adolescence, Hardcover by Greydanus, Donald E. (EDT); Calles, Joseph L., Jr. (EDT); Patel, Dilip R. (EDT); Nazeer, Ahsan (EDT); Merrick, Joav (EDT), ISBN 1536102415, ISBN-13 9781536102413, Brand New, Free shipping in the US

About this product

Product Identifiers

PublisherNOVA Science Publishers, Incorporated
ISBN-101536102415
ISBN-139781536102413
eBay Product ID (ePID)240354534

Product Key Features

Number of Pages310 Pages
LanguageEnglish
Publication NameClinical Aspects of Psychopharmacology in Childhood and Adolescence
SubjectPediatrics, Psychiatry / Psychopharmacology, Psychopathology / General
Publication Year2017
TypeTextbook
AuthorJoseph L. Calles
Subject AreaPsychology, Medical
SeriesPediatrics, Child and Adolescent Health (Series Editor: Joav Merrick - National Institute of Child Health and Human Development, Ministry of Social Affairs, Jerusalem) Ser.
FormatHardcover

Dimensions

Item Weight27 Oz
Item Length10.2 in
Item Width7.1 in

Additional Product Features

Edition Number2
LCCN2016-954171
Dewey Edition22
IllustratedYes
Dewey Decimal615/.780835
Table Of ContentFor Complete Table of Contents, please visit our website at: https://www.novapublishers.com/catalog/product_info.php'products_id=59929
SynopsisA large proportion of children and youth have mental health problems that follow different trajectories over time. This book presents the psychopharmacologic agents that are available for children and adolescents, as well as the side effects, drug interactions, and the monitoring parametres of these medications., The search for medicinal agents to improve emotional, behavioral, and psychiatric conditions of Homo sapiens has occurred for ages. The 20th century witnessed the development of psychopharmacologic agents, including stimulants in the 1930s (and 1950s), chlorpromazine in the 1950s, lithium, tricyclic antidepressants, benzodiazepines, SSRIs (1990s), and others. The proper use of these agents in the pediatric population continues to be an active study. Atypical antipsychotics have been approved by the FDA for children and adolescents though their safety and efficacy in the pediatric population but must be assiduously ascertained with ongoing research in the eternal iatric maxim of primum non nocere. The science of evidence-based pharmacotherapy for mental health disorders in children and adolescents is finally emerging. Exciting discoveries await the researchers of this still early 21st century lead by the crucial collaborative efforts of academicians, pharmaceutical scientists, and medical government authorities. Controversies regarding the use of various psychopharmacologic agents for the pediatric population continue in the 21st century, requiring further research and insightful judgment for its applications in this vulnerable population. Excessive and unnecessary psychopharmacologic agents should be avoided in the pediatric population with behavioral/emotional/psychiatric conditions/disorders. In this second edition, the authors present updated information about psychopharmacology in childhood and adolescence.
LC Classification NumberRJ504.7.C55 2017

All listings for this product

Buy it now
Any condition
New
Pre-owned
No ratings or reviews yet
Be the first to write a review